
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $3.5B | $4.4B | $5.7B | $6.4B | |
Revenue Growth (YoY) | 12.4% | 0.18% | 26.39% | 29.29% | 11.4% | |
Cost of Revenues | $3.1B | $3.1B | $4B | $5.1B | $5.7B | |
Gross Profit | $370.2M | $416.7M | $456.9M | $587.5M | $703.2M | |
Gross Profit Margin | 10.6% | 11.91% | 10.34% | 10.28% | 11.05% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $202.8M | $230.1M | $281.6M | $328.7M | $383.4M | |
Other Inc / (Exp) | -$1.8M | -$16.2M | $23.2M | -$2.9M | $338K | |
Operating Expenses | $202.8M | $230.1M | $281.6M | $328.7M | $383.4M | |
Operating Income | $167.4M | $186.6M | $175.3M | $258.8M | $319.9M | |
Net Interest Expenses | $19.9M | $18.5M | $39.2M | $78.2M | $65.3M | |
EBT. Incl. Unusual Items | $145.6M | $151.9M | $159.3M | $177.7M | $254.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $40.7M | $36.1M | $26.3M | $51.5M | $74M | |
Net Income to Company | $105M | $115.7M | $133M | $126.1M | $180.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $105M | $115.7M | $133M | $126.1M | $180.9M | |
Basic EPS (Cont. Ops) | $2.17 | $2.19 | $2.50 | $2.37 | $3.37 | |
Diluted EPS (Cont. Ops) | $2.16 | $2.17 | $2.47 | $2.33 | $3.31 | |
Weighted Average Basic Share | $48.3M | $52.7M | $53.2M | $53.3M | $53.6M | |
Weighted Average Diluted Share | $48.6M | $53.2M | $53.8M | $54.2M | $54.6M | |
EBITDA | $248.1M | $275.9M | $297.7M | $362.9M | $415.8M | |
EBIT | $165.6M | $170.4M | $198.5M | $255.8M | $320.2M | |
Revenue (Reported) | $3.5B | $3.5B | $4.4B | $5.7B | $6.4B | |
Operating Income (Reported) | $167.4M | $186.6M | $175.3M | $258.8M | $319.9M | |
Operating Income (Adjusted) | $165.6M | $170.4M | $198.5M | $255.8M | $320.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $818.3M | $784.4M | $1.3B | $1.4B | $1.6B | |
Revenue Growth (YoY) | 10.1% | -4.15% | 60.24% | 12.4% | 16.66% | |
Cost of Revenues | $738.1M | $727.9M | $1.2B | $1.3B | $1.5B | |
Gross Profit | $80.2M | $56.5M | $99.7M | $133.4M | $170.7M | |
Gross Profit Margin | 9.8% | 7.2% | 7.94% | 9.44% | 10.36% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $53.4M | $55.5M | $78M | $88.6M | $99.5M | |
Other Inc / (Exp) | -$13.9M | -$448K | -$1.4M | -$116K | -$1.1M | |
Operating Expenses | $53.4M | $55.5M | $78M | $88.6M | $99.5M | |
Operating Income | $26.7M | $1M | $21.7M | $44.8M | $71.2M | |
Net Interest Expenses | $4.6M | $2.9M | $18.5M | $18M | $7.8M | |
EBT. Incl. Unusual Items | $8.2M | -$2.3M | $1.8M | $26.7M | $62.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.4M | -$619K | $510K | $7.7M | $18.1M | |
Net Income to Company | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Basic EPS (Cont. Ops) | $0.12 | -$0.03 | $0.02 | $0.35 | $0.82 | |
Diluted EPS (Cont. Ops) | $0.12 | -$0.03 | $0.02 | $0.35 | $0.81 | |
Weighted Average Basic Share | $49.5M | $53.2M | $53.2M | $53.5M | $53.8M | |
Weighted Average Diluted Share | $50M | $53.2M | $53.9M | $54.4M | $54.7M | |
EBITDA | $37.7M | $20.8M | $48M | $69.3M | $91.5M | |
EBIT | $12.9M | $583K | $20.3M | $44.7M | $70.1M | |
Revenue (Reported) | $818.3M | $784.4M | $1.3B | $1.4B | $1.6B | |
Operating Income (Reported) | $26.7M | $1M | $21.7M | $44.8M | $71.2M | |
Operating Income (Adjusted) | $12.9M | $583K | $20.3M | $44.7M | $70.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.6B | $3.5B | $4.9B | $5.9B | $6.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.2B | $3.1B | $4.4B | $5.2B | $5.9B | |
Gross Profit | $402.6M | $393M | $500.1M | $621.1M | $740.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $211.9M | $232.1M | $304.1M | $339.3M | $394.3M | |
Other Inc / (Exp) | -$15.8M | -$2.8M | $22.2M | -$1.6M | -$604K | |
Operating Expenses | $211.9M | $232.1M | $304.1M | $339.3M | $394.3M | |
Operating Income | $190.7M | $160.8M | $196M | $281.8M | $346.3M | |
Net Interest Expenses | $15.7M | $16.7M | $54.8M | $77.7M | $55.1M | |
EBT. Incl. Unusual Items | $159.1M | $141.3M | $163.4M | $202.5M | $290.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $44.6M | $33.1M | $27.4M | $58.8M | $84.4M | |
Net Income to Company | $114.6M | $108.2M | $136M | $143.8M | $206.2M | |
Minority Interest in Earnings | -$5K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $114.6M | $108.2M | $136M | $143.8M | $206.2M | |
Basic EPS (Cont. Ops) | $2.37 | $2.02 | $2.55 | $2.69 | $3.83 | |
Diluted EPS (Cont. Ops) | $2.36 | $1.99 | $2.52 | $2.65 | $3.78 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $260.7M | $258.9M | $324.9M | $384.1M | $438M | |
EBIT | $174.9M | $158.1M | $218.2M | $280.2M | $345.7M | |
Revenue (Reported) | $3.6B | $3.5B | $4.9B | $5.9B | $6.6B | |
Operating Income (Reported) | $190.7M | $160.8M | $196M | $281.8M | $346.3M | |
Operating Income (Adjusted) | $174.9M | $158.1M | $218.2M | $280.2M | $345.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $818.3M | $784.4M | $1.3B | $1.4B | $1.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $738.1M | $727.9M | $1.2B | $1.3B | $1.5B | |
Gross Profit | $80.2M | $56.5M | $99.7M | $133.4M | $170.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $53.4M | $55.5M | $78M | $88.6M | $99.5M | |
Other Inc / (Exp) | -$13.9M | -$448K | -$1.4M | -$116K | -$1.1M | |
Operating Expenses | $53.4M | $55.5M | $78M | $88.6M | $99.5M | |
Operating Income | $26.7M | $1M | $21.7M | $44.8M | $71.2M | |
Net Interest Expenses | $4.6M | $2.9M | $18.5M | $18M | $7.8M | |
EBT. Incl. Unusual Items | $8.2M | -$2.3M | $1.8M | $26.7M | $62.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.4M | -$619K | $510K | $7.7M | $18.1M | |
Net Income to Company | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Basic EPS (Cont. Ops) | $0.12 | -$0.03 | $0.02 | $0.35 | $0.82 | |
Diluted EPS (Cont. Ops) | $0.12 | -$0.03 | $0.02 | $0.35 | $0.81 | |
Weighted Average Basic Share | $49.5M | $53.2M | $53.2M | $53.5M | $53.8M | |
Weighted Average Diluted Share | $50M | $53.2M | $53.9M | $54.4M | $54.7M | |
EBITDA | $37.7M | $20.8M | $48M | $69.3M | $91.5M | |
EBIT | $12.9M | $583K | $20.3M | $44.7M | $70.1M | |
Revenue (Reported) | $818.3M | $784.4M | $1.3B | $1.4B | $1.6B | |
Operating Income (Reported) | $26.7M | $1M | $21.7M | $44.8M | $71.2M | |
Operating Income (Adjusted) | $12.9M | $583K | $20.3M | $44.7M | $70.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $326.7M | $200.5M | $248.7M | $217.8M | $455.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $548.3M | $596.6M | $837.3M | $887.8M | $1.1B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $30.2M | -- | -- | -- | -- | |
Other Current Assets | -- | $86.3M | $176.4M | $135.8M | $95.5M | |
Total Current Assets | $1.1B | $1.2B | $1.7B | $1.9B | $2.2B | |
Property Plant And Equipment | $563.5M | $591.9M | $696.7M | $836.4M | $949.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $215.1M | $581.7M | $871.8M | $857.7M | $856.9M | |
Other Intangibles | $61M | $171.3M | $249.4M | $227.6M | $207.9M | |
Other Long-Term Assets | $12.8M | $15.1M | $21.8M | $20.5M | $22.3M | |
Total Assets | $2B | $2.5B | $3.5B | $3.8B | $4.2B | |
Accounts Payable | $245.9M | $273.5M | $535M | $629M | $624.3M | |
Accrued Expenses | $105.5M | $98.2M | $137.1M | $134.9M | $157.7M | |
Current Portion Of Long-Term Debt | $47.7M | $67.2M | $78.1M | $72.9M | $74.6M | |
Current Portion Of Capital Lease Obligations | $73M | $61.6M | $72.6M | $96.4M | $122M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $764.4M | $759.1M | $1.1B | $1.3B | $1.7B | |
Long-Term Debt | $268.8M | $594.2M | $1.1B | $885.4M | $660.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1.6B | $2.4B | $2.6B | $2.8B | |
Common Stock | $5K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | $958K | $698K | -$2.6M | -$788K | -$4.2M | |
Common Equity | $714.8M | $990.1M | $1.1B | $1.2B | $1.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $37K | -- | -- | -- | -- | |
Total Equity | $714.8M | $990.1M | $1.1B | $1.2B | $1.4B | |
Total Liabilities and Equity | $2B | $2.5B | $3.5B | $3.8B | $4.2B | |
Cash and Short Terms | $326.7M | $200.5M | $248.7M | $217.8M | $455.8M | |
Total Debt | $316.6M | $661.5M | $1.1B | $958.3M | $734.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $212.8M | $173.5M | $94.8M | $177.6M | $351.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $479M | $584.6M | $955.2M | $1B | $1B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $46.2M | $120.3M | $118.6M | -- | -- | |
Other Current Assets | -- | -- | -- | $138M | $126.8M | |
Total Current Assets | $1.1B | $1.2B | $1.7B | $2B | $2.2B | |
Property Plant And Equipment | $620.7M | $603.6M | $702.8M | $856.9M | $961.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $588.8M | $583.5M | $871.7M | $857.7M | $856.9M | |
Other Intangibles | $181.2M | $167.7M | $243.3M | $222.4M | $203.3M | |
Other Long-Term Assets | $18.5M | $27.1M | $23.2M | $18.1M | $22M | |
Total Assets | $2.5B | $2.6B | $3.5B | $4B | $4.2B | |
Accounts Payable | $258.7M | $289.6M | $561.3M | $632.5M | $795.3M | |
Accrued Expenses | $121.5M | $118.9M | $117M | $144.5M | $137.5M | |
Current Portion Of Long-Term Debt | $61.5M | $66M | $77.5M | $89.5M | $68.1M | |
Current Portion Of Capital Lease Obligations | $71.3M | $59.3M | $75.6M | $100.7M | $126.8M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $796.8M | $844.2M | $1.1B | $1.4B | $1.8B | |
Long-Term Debt | $592.1M | $599.3M | $1B | $862.2M | $543.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6B | $1.6B | $2.4B | $2.7B | $2.8B | |
Common Stock | $6K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | $1.4M | $1.7M | -$2.5M | -$2.1M | -$4.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $35K | -- | -- | -- | -- | |
Total Equity | $901.4M | $987.8M | $1.1B | $1.2B | $1.4B | |
Total Liabilities and Equity | $2.5B | $2.6B | $3.5B | $4B | $4.2B | |
Cash and Short Terms | $212.8M | $173.5M | $94.8M | $177.6M | $351.6M | |
Total Debt | $653.6M | $665.3M | $1.1B | $951.7M | $612M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $105M | $115.7M | $133M | $126.1M | $180.9M | |
Depreciation & Amoritzation | $82.5M | $105.6M | $99.2M | $107M | $95.5M | |
Stock-Based Compensation | $2.3M | $10.5M | $7.4M | $11.8M | $15.1M | |
Change in Accounts Receivable | -$10.7M | -$56.5M | -$217.5M | -$246.7M | -$105M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $313M | $79.7M | $83.3M | $198.6M | $508.3M | |
Capital Expenditures | $64.4M | $133.8M | $94.7M | $103M | $126.6M | |
Cash Acquisitions | -- | -$607M | -$478.4M | $9.3M | -- | |
Cash From Investing | -$42.5M | -$691.3M | -$481.9M | -$30M | -$27.2M | |
Dividends Paid (Ex Special Dividend) | -$11.6M | -$12.6M | -$12.8M | -$12.8M | -$12.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $33.9M | $561.7M | $658.1M | $450.2M | -- | |
Long-Term Debt Repaid | -$68.9M | -$213.9M | -$175.3M | -$637.2M | -$224.5M | |
Repurchase of Common Stock | -$11.5M | -$14.7M | -$6M | -- | -- | |
Other Financing Activities | -$5.3M | -$13.6M | -$12M | -$5.5M | -$7M | |
Cash From Financing | -$62.8M | $485.7M | $452M | -$205.3M | -$244.4M | |
Beginning Cash (CF) | $123.4M | $331M | $205.6M | $259M | $223.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $207.7M | -$125.8M | $53.5M | -$36.7M | $236.7M | |
Ending Cash (CF) | $331M | $205.6M | $259M | $223.5M | $461.4M | |
Levered Free Cash Flow | $248.6M | -$54.1M | -$11.3M | $95.5M | $381.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Depreciation & Amoritzation | $24.9M | $20.2M | $27.7M | $24.6M | $21.4M | |
Stock-Based Compensation | $6.2M | $1.6M | $2.4M | $2.4M | $5M | |
Change in Accounts Receivable | $2.8M | -$20.3M | -$154.7M | -$155.9M | -$86M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $8M | $6.6M | -$115.3M | -$28.5M | $66.2M | |
Capital Expenditures | $19.1M | $33.2M | $13.8M | $10.4M | $40.6M | |
Cash Acquisitions | -$613.2M | -$4.1M | -- | -- | -- | |
Cash From Investing | -$630.2M | -$32.9M | -$6.5M | $4.2M | -$33.2M | |
Dividends Paid (Ex Special Dividend) | -$2.9M | -$3.2M | -$3.2M | -$3.2M | -$4.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $500M | $30M | $75M | -- | -- | |
Long-Term Debt Repaid | -$159.4M | -$26.5M | -$106.5M | -$7M | -$123.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8.2M | -$2M | -$2.4M | -$5.5M | -$10.5M | |
Cash From Financing | $508.5M | -$1.2M | -$36.6M | -$15.1M | -$137.3M | |
Beginning Cash (CF) | $331M | $205.6M | $259M | $223.5M | $461.4M | |
Foreign Exchange Rate Adjustment | $259K | $502K | -$79K | -$314K | $11K | |
Additions / Reductions | -$113.8M | -$27.5M | -$158.4M | -$39.4M | -$104.3M | |
Ending Cash (CF) | $217.5M | $178.6M | $100.5M | $183.8M | $357.2M | |
Levered Free Cash Flow | -$11.1M | -$26.6M | -$129.2M | -$38.9M | $25.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $114.6M | $108.2M | $136M | $143.8M | $206.2M | |
Depreciation & Amoritzation | $85.8M | $100.9M | $106.7M | $103.9M | $92.3M | |
Stock-Based Compensation | $7.9M | $5.9M | $8.3M | $11.9M | $17.8M | |
Change in Accounts Receivable | $21.6M | -$79.5M | -$352M | -$247.8M | -$35.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $326.4M | $78.4M | -$38.6M | $285.4M | $602.9M | |
Capital Expenditures | $74.1M | $147.9M | $75.4M | $99.6M | $156.7M | |
Cash Acquisitions | -$613.2M | $2.2M | -$474.4M | $9.3M | -- | |
Cash From Investing | -$670.3M | -$93.9M | -$455.5M | -$19.4M | -$64.6M | |
Dividends Paid (Ex Special Dividend) | -$11.6M | -$12.9M | -$12.8M | -$12.8M | -$14M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $527.1M | $91.7M | $703.1M | $375.2M | -- | |
Long-Term Debt Repaid | -$213.3M | -$81M | -$255.4M | -$537.7M | -$340.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$12.2M | -$7.4M | -$12.3M | -$8.7M | -$11.9M | |
Cash From Financing | $464.8M | -$24M | $416.7M | -$183.8M | -$366.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $121M | -$39.5M | -$77.4M | $82.3M | $171.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $252.3M | -$69.6M | -$113.9M | $185.8M | $446.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.8M | -$1.7M | $1.3M | $18.9M | $44.2M | |
Depreciation & Amoritzation | $24.9M | $20.2M | $27.7M | $24.6M | $21.4M | |
Stock-Based Compensation | $6.2M | $1.6M | $2.4M | $2.4M | $5M | |
Change in Accounts Receivable | $2.8M | -$20.3M | -$154.7M | -$155.9M | -$86M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $8M | $6.6M | -$115.3M | -$28.5M | $66.2M | |
Capital Expenditures | $19.1M | $33.2M | $13.8M | $10.4M | $40.6M | |
Cash Acquisitions | -$613.2M | -$4.1M | -- | -- | -- | |
Cash From Investing | -$630.2M | -$32.9M | -$6.5M | $4.2M | -$33.2M | |
Dividends Paid (Ex Special Dividend) | -$2.9M | -$3.2M | -$3.2M | -$3.2M | -$4.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $500M | $30M | $75M | -- | -- | |
Long-Term Debt Repaid | -$159.4M | -$26.5M | -$106.5M | -$7M | -$123.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8.2M | -$2M | -$2.4M | -$5.5M | -$10.5M | |
Cash From Financing | $508.5M | -$1.2M | -$36.6M | -$15.1M | -$137.3M | |
Beginning Cash (CF) | $331M | $205.6M | $259M | $223.5M | $461.4M | |
Foreign Exchange Rate Adjustment | $259K | $502K | -$79K | -$314K | $11K | |
Additions / Reductions | -$113.8M | -$27.5M | -$158.4M | -$39.4M | -$104.3M | |
Ending Cash (CF) | $217.5M | $178.6M | $100.5M | $183.8M | $357.2M | |
Levered Free Cash Flow | -$11.1M | -$26.6M | -$129.2M | -$38.9M | $25.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.